Abel E Jason, Wong Kelvin, Sado Martins, Leverson Glen E, Patel Sutchin R, Downs Tracy M, Jarrard David F
Department of Urology, University of Wisconsin School of Medicine and Public Health, 1685 Highland Ave, Madison, WI 53705-2281, USA.
Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
JSLS. 2014 Apr-Jun;18(2):282-7. doi: 10.4293/108680813X13693422518551.
To evaluate the effect of operative time on the risk of symptomatic venous thromboembolic events (VTEs) in patients undergoing robot-assisted radical prostatectomy (RARP).
We reviewed the records of all patients at our institution who underwent RARP by a single surgeon from January 2007 until April 2011. Clinical and pathologic information and VTE incidence were recorded for each patient and analyzed by use of logistic regression to evaluate for association with VTE risk. All patients had mechanical prophylaxis, and beginning in February 2008, a single dose of unfractionated heparin, 5000 U, was administered before surgery.
A total of 549 consecutive patients were identified, with a median follow-up period of 8 months. During the initial 30 days postoperatively, 10 patients (1.8%) had a VTE (deep venous thrombosis in 7 and pulmonary embolism in 3). The median operative time was 177 minutes (range, 121-360 minutes). An increase in operative time of 30 or 60 minutes was associated with 1.6 and 2.8 times increased VTE risks. A 5-point increase in body mass index and need for blood transfusion were also associated with increased risk of VTEs (odds ratios of 2.0 and 11.8, respectively). Heparin prophylaxis was not associated with a significant VTE risk reduction but also was not associated with a significant increase in estimated blood loss (P = .23) or transfusion rate (P = .37).
A prolonged operative time increases the risk of symptomatic VTEs after RARP. Future studies are needed to evaluate the best VTE prophylactic approach in patients at risk.
评估手术时间对接受机器人辅助根治性前列腺切除术(RARP)患者发生有症状静脉血栓栓塞事件(VTE)风险的影响。
我们回顾了2007年1月至2011年4月间在我院由同一外科医生实施RARP的所有患者的记录。记录每位患者的临床和病理信息以及VTE发生率,并采用逻辑回归分析以评估与VTE风险的相关性。所有患者均接受机械预防措施,并且从2008年2月开始,术前给予5000 U普通肝素单次剂量。
共确定了549例连续患者,中位随访期为8个月。术后最初30天内,10例患者(1.8%)发生VTE(7例深静脉血栓形成,3例肺栓塞)。中位手术时间为177分钟(范围121 - 360分钟)。手术时间增加30或60分钟分别使VTE风险增加1.6倍和2.8倍。体重指数增加5个单位以及需要输血也与VTE风险增加相关(优势比分别为2.0和11.8)。肝素预防与VTE风险显著降低无关,但也与估计失血量显著增加(P = 0.23)或输血率增加(P = 0.37)无关。
手术时间延长会增加RARP术后有症状VTE的风险。需要进一步研究以评估高危患者最佳的VTE预防方法。